Escitalopram oxalate is the most selective selective serotonin reuptake inhibitor (SSRI) available. It targets and binds with extreme specificity to the primary allosteric site of the presynaptic serotonin transporter (SERT) protein, completely preventing the reabsorption of serotonin into neurons. This selective action increases intrasynaptic serotonin concentrations to enhance neurotransmission across serotonergic pathways, correcting mood imbalances with minimal interaction with other neurotransmitter receptors.